The life sciences industry is currently in a state of significant change and crisis as a result of its more elderly population relative to other countries. The response to data utilization opportunities and the entry of different industries due to technological developments such as ICT and AI are inevitably changing this industry. The prediction is that M&As may become commonplace within this sector, and these would effectively eliminate many companies.

At the same time, there is an expectation that there will be further innovations within the life sciences industry. There is also an expectancy that an increase in value from technologies such as biosensors will emerge in the future. With the growth of emerging markets in other countries comes potentially larger markets. Also, Japan holds approximately 10% of the world’s market share in both medical products and medical devices and has continued to expand overseas. One can consider this a suitable environment for life sciences to develop.

Here at RSM Shiodome Partners, we are familiar with working with the life sciences industry, and we can help you with managing your business.

Contact us

Complete this form and an RSM Shiodome Partners representative will be in touch.